People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Pharmaceuticals, Biotechnology, Computers, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Engage Therapeutics, Inc. | — | Pharmaceuticals | Series B | $30.6M | $238.0M | 2019 |
| Xalud Therapeutics, Inc. | — | Biotechnology | Series B | $30.5M | $495.1M | 2015 |
| AtomBeam Technologies Inc. | — | Computers | Series A | $12.0M | $34.3M | 2024 |
| Spinifex Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $6.2M | $191.0M | 2014 |
| Oska, Inc. | — | Other | Pre-Seed | $755K | $17.4M | 2015 |
Stephen Collins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Collins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Heath Lukatch | 2 | 10 |
| Joshua Cooper | 1 | 21 |
| John Rogers | 1 | 20 |
| Brent Ahrens | 1 | 7 |
| Paul B. Manning | 1 | 6 |
| Declan Doogan | 1 | 6 |
| Sean Stalfort | 1 | 5 |
| Gerry Brunk | 1 | 5 |
| Gregory Mayes | 1 | 5 |
| Michael Brower | 1 | 3 |
| Mark Theeuwes | 1 | 3 |
| Greg Caltabiano | 1 | 3 |
| Joshua Funder | 1 | 3 |
| Orrin Devinsky | 1 | 3 |
| Warren Lammert | 1 | 3 |
| Diem B. Nguyen | 1 | 2 |
| Stephen D. Collins | 1 | 2 |
| Gerry D. Brunk | 1 | 2 |
| Jayson Rieger | 1 | 2 |
| Heath D. Lukatch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.